Stay updated on Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial
Sign up to get notified when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FHY0dVSvfdFBYEeUtjfybANUaEUk.uncropped.jpg&w=3840&q=75)
Latest updates to the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check3 days agoChange DetectedDifference1%
- Check4 days agoChange DetectedThe study has expanded to include 78 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.3%
- Check5 days agoChange DetectedDifference1%
- Check8 days agoChange DetectedDifference1%
- Check9 days agoChange DetectedDifference1%
- Check10 days agoChange DetectedDifference1%
Stay in the know with updates to Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.